Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
Matthew J BoyerDavid J CarpenterJeffrey R GingrichSudha R RamanDeepika SirohiAmir Alishahi TabrizAlexis Rompre-BrodeurJoseph LunyeraFahmin BasherRhonda L BittingAndrzej KosinskiSarah CantrellAdelaide M GordonBelinda EarJennifer M GierischMorgan JacobsKaren M GoldsteinPublished in: Prostate cancer and prostatic diseases (2024)
Genomic classifiers provide a small but consistent improvement upon the prognostic ability of clinical classification schemes, which may be helpful when treatment decisions are uncertain. However, evidence from current management-era data and of the predictive ability of these tests is needed.